Trial Profile
An Italian Observational Study to Evaluate Fracture Outcomes, Compliance to Treatment, Back Pain, Health-Related Quality of Life in Patients With Severe Osteoporosis Treated According to Common Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2011
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Male osteoporosis; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms ISSO
- Sponsors Eli Lilly and Company
- 05 May 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 05 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Mar 2010 Planned end date changed from 1 Dec 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.